Literature DB >> 20822826

Analysis of wait times and costs during the peri-diagnostic period for non-small cell lung cancer.

Winson Y Cheung1, James R Butler, Erich V Kliewer, Alain A Demers, Grace Musto, Stephen Welch, Gokulan Sivananthan, Sri Navaratnam.   

Abstract

PURPOSE: To determine the wait times and healthcare costs around the time of non-small cell lung cancer (NSCLC) diagnosis for a large, population-based cohort of patients.
METHODS: Data on baseline demographics, diagnostic and staging tests, timelines of investigations, and frequency of physician visits and hospital admissions were obtained from a provincial cancer registry and health administrative databases for 2852 patients, who were diagnosed with NSCLC from 1996 to 2000 in Manitoba, Canada. Dates between investigations were used to determine wait times surrounding diagnosis and fee codes for physician and hospital services were used to estimate costs.
RESULTS: The median wait times from chest x-ray to chest computed tomography (CT) scan and from CT scan to definitive histological diagnosis were 8 (inter-quartile range 1-25) and 18 (inter-quartile range 3-42) days, respectively. At least 25% of patients waited more than 55 days from initial suspicion on chest x-ray to final diagnosis of NSCLC. The mean cost per case of NSCLC diagnosis was $6,978 (in Canadian dollars) where the majority of expenses was attributed to hospital admissions and repeated physician visits before a diagnosis was confirmed.
CONCLUSIONS: Despite clinical suspicion for NSCLC, a significant number of patients wait more than 8 weeks for a definitive diagnosis. Substantial costs are incurred by the Canadian universal healthcare system in the months surrounding diagnosis. Establishment of more efficient and cost-effective healthcare delivery in the peri-diagnostic time period may benefit the system as well as the patients.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20822826     DOI: 10.1016/j.lungcan.2010.08.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

1.  Chemotherapy uptake and wait times in early-stage non-small-cell lung cancer.

Authors:  S Gray; J Bu; N Saint-Jacques; D Rayson; T Younis
Journal:  Curr Oncol       Date:  2012-10       Impact factor: 3.677

2.  Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer.

Authors:  Nicole Ezer; Rajwanth R Veluswamy; Grace Mhango; Kenneth E Rosenzweig; Charles A Powell; Juan P Wisnivesky
Journal:  J Thorac Oncol       Date:  2015-08       Impact factor: 15.609

3.  A retrospective analysis of delays in the diagnosis of lung cancer and associated costs.

Authors:  Thomas R Gildea; Stacey DaCosta Byfield; D Kyle Hogarth; David S Wilson; Curtis C Quinn
Journal:  Clinicoecon Outcomes Res       Date:  2017-05-12

4.  Determining the Cancer Diagnostic Interval Using Administrative Health Care Data in a Breast Cancer Cohort.

Authors:  Patti A Groome; Colleen Webber; Marlo Whitehead; Rahim Moineddin; Eva Grunfeld; Andrea Eisen; Julie Gilbert; Claire Holloway; Jonathan C Irish; Hugh Langley
Journal:  JCO Clin Cancer Inform       Date:  2019-05

5.  Understanding the patient journey to diagnosis of lung cancer.

Authors:  Yichen Zhang; Michael J Simoff; David Ost; Oliver J Wagner; James Lavin; Beth Nauman; Mei-Chin Hsieh; Xiao-Cheng Wu; Brian Pettiford; Lizheng Shi
Journal:  BMC Cancer       Date:  2021-04-14       Impact factor: 4.430

6.  Reasons for lack of referral to medical oncology for systemic therapy in stage IV non-small-cell lung cancer: comparison of 2003-2006 with 2010-2011.

Authors:  J J Ko; R Tudor; H Li; M Liu; K Skolnik; W Kells Boland; J Macklow; D Morris; D G Bebb
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

7.  Wait Times Experienced by Lung Cancer Patients in the BC Southern Interior to Obtain Oncologic Care: Exploration of the Intervals from First Abnormal Imaging to Oncologic Treatment.

Authors:  David Van de Vosse; Rezwan Chowdhury; Andrew Boyce; Ross Halperin
Journal:  Cureus       Date:  2015-09-22

8.  Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment.

Authors:  Nicole Ezer; Asma Navasakulpong; Kevin Schwartzman; Linda Ofiara; Anne V Gonzalez
Journal:  BMC Pulm Med       Date:  2017-12-08       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.